These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11239220)

  • 1. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs.
    Platzbecker U; Prange-Krex G; Bornhäuser M; Koch R; Soucek S; Aikele P; Haack A; Haag C; Schuler U; Berndt A; Rutt C; Ehninger G; Hölig K
    Transfusion; 2001 Feb; 41(2):184-9. PubMed ID: 11239220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors.
    Stroncek D; Shawker T; Follmann D; Leitman SF
    Transfusion; 2003 May; 43(5):609-13. PubMed ID: 12702182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
    Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
    Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF.
    de Fabritiis P; Iori AP; Mengarelli A; Gozzer M; Ferrazza G; De Propris MS; Romano A; Arcese W
    Transfusion; 2001 Feb; 41(2):190-5. PubMed ID: 11239221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
    Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
    Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization.
    Picardi M; De Rosa G; Selleri C; Scarpato N; Soscia E; Martinelli V; Ciancia R; Rotoli B
    Haematologica; 2003 Jul; 88(7):794-800. PubMed ID: 12857559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.
    Platzbecker U; Bornhäuser M; Zimmer K; Lerche L; Rutt C; Ehninger G; Hölig K
    Transfusion; 2005 Jan; 45(1):11-5. PubMed ID: 15647012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
    Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
    Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemia.
    Yannaki E; Psatha N; Athanasiou E; Karponi G; Constantinou V; Papadopoulou A; Tasouli A; Kaloyannidis P; Batsis I; Arsenakis M; Anagnostopoulos A; Fassas A
    Hum Gene Ther; 2010 Mar; 21(3):299-310. PubMed ID: 19795976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
    Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
    Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization.
    Dincer AP; Gottschall J; Margolis DA
    J Pediatr Hematol Oncol; 2004 Nov; 26(11):761-3. PubMed ID: 15543014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
    Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
    Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of single-dose G-CSF in mobilization and reconstruction of allogeneic peripheral blood stem cell transplantation].
    Tian H; Zhou SY
    Ai Zheng; 2003 Dec; 22(12):1325-9. PubMed ID: 14693061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
    van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
    J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.